Home Sita Met 50/500mg Tablet
Sita Met 50/500mg Tablet – Available in Pakistan
Sita Met 50/500mg Tablet Pack — Rx Prescription Diabetes Medicine CCL – View Product Detail
Sita Met 50/500mg Tablet – Available in Pakistan
Sita Met 50/500mg Tablet Pack — Rx Prescription Diabetes Medicine CCL – View Product Detail

Sita Met 50/500mg Tablet

Sita Met 50/500mg Tablet is a prescription dual-combination for Type 2 diabetes: Sitagliptin 50mg (DPP-4 inhibitor) + Metformin 500mg (biguanide). Lowers fasting and post-meal blood glucose. Suitable for patients starting Metformin or at higher GI risk. Rx required.

Sale price Rs. 631

Pay in 3 Installments of

Rs.

241

  • Oxagit Doxazosin 2mg Tablets – Available in Pakistan
    Oxagit Doxazosin 2mg Tablets
    Sale priceRs. 468
  • 20% SA + Clobetasol Ointment – Available in Pakistan
    20% SA + Clobetasol Ointment
    Sale priceRs. 1,110
  • Cholce-D Vitamin D3 200,000 IU IM Injection – Available in Pakistan
    Cholce-D Vitamin D3 200,000 IU IM Injection
    Sale priceRs. 162
Availability: In stock SKU: DRM-GM-0654
Tags: Anti-Diabetic Biguanide Blood Sugar Control CCL Pharmaceuticals DPP-4 Inhibitor medicines Metformin Prescription Medicine Rx Medicines Sitagliptin tablets 2 Diabetes
Sita Met 50/500mg Tablet – Available in Pakistan

Sita Met 50/500mg Tablet

Rs. 631

Sita Met 50/500mg Tablet

Sita Met 50/500mg Tablet is a prescription fixed-dose combination of Sitagliptin 50mg (DPP-4 inhibitor) and Metformin 500mg (biguanide) for blood glucose management in adults with Type 2 diabetes mellitus. Sitagliptin stimulates glucose-dependent insulin release and reduces excess glucagon secretion, while Metformin decreases hepatic glucose production and improves peripheral insulin sensitivity. This combination is prescribed when monotherapy is insufficient.

  • Active ingredients: Sitagliptin 50mg + Metformin 500mg
  • Dual mechanism: DPP-4 inhibition + biguanide action for complementary glucose control
  • Lowers both fasting and post-meal blood glucose levels
  • Metformin 500mg — initial/low dose suitable for patients at higher GI risk
  • Prescription Rx combination — twice-daily dosing with meals

How to Use

Take Sita Met 50/500mg twice daily with meals to reduce the risk of gastrointestinal side effects, as directed by your doctor. Swallow whole — do not crush or chew. Follow the prescribed diet and exercise programme. Monitor blood glucose regularly. For more prescription diabetes medicines at Derma.pk. Submit prescription via email at sales@derma.pk or WhatsApp +92-320-5999650. See the full tablet and capsule range.

Usage & Benefits
  • Sitagliptin 50mg (DPP-4 inhibitor) stimulates insulin release in a glucose-dependent manner
  • Metformin 500mg reduces hepatic glucose output and improves insulin sensitivity
  • Complementary dual mechanism provides effective glycaemic control in T2DM
  • 500mg Metformin dose reduces GI side effects during initiation or for sensitive patients
  • Convenient fixed-dose combination improves adherence over separate tablets
How To Use

1. Take Sita Met 50/500mg twice daily with meals as prescribed by your doctor.
2. Swallow the tablet whole — do not crush, split, or chew.
3. Taking with food significantly reduces the risk of nausea or stomach discomfort.
4. Monitor blood glucose levels regularly and report any persistent side effects.
5. Store below 25°C in a dry place. Do not stop without consulting your physician.

FAQs

What is Sita Met 50/500mg Tablet used for?

Sita Met 50/500mg combines Sitagliptin 50mg (DPP-4 inhibitor) and Metformin 500mg (biguanide) to control blood sugar in Type 2 diabetes when diet, exercise, or monotherapy is insufficient.

Do I need a prescription for Sita Met 50/500mg?

Yes. Both components are prescription-only. Submit a valid prescription via email at sales@derma.pk or WhatsApp +92-320-5999650.

How is Sita Met 50/500mg different from 50/850mg or 50/1000mg?

All three contain Sitagliptin 50mg but differ in Metformin dose. 500mg is used for initiation or GI-sensitive patients; 850mg and 1000mg provide more intensive glucose lowering.